ask="0.3400"
ask_size="7000"
average_daily_volume="1618170"
bid="0.2853"
bid_size="300"
book_value="0.1680"
change="+0.0006"
change_from_200_day_moving_average="-0.0638"
change_from_50_day_moving_average="-0.0234"
change_from_52_week_high="-0.8295"
change_From_52_week_low="0.0085"
change_in_percent="+0.2070%"
close="0.2905"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.2996"
high_52_weeks="1.1200"
last_trade_date="1/17/2017"
last_trade_price="0.2905"
last_trade_size="1732"
last_trade_time="4:00pm"
low="0.2903"
low_52_weeks="0.2820"
market_capitalization="74.70M"
moving_average_200_day="0.3543"
moving_average_50_day="0.3139"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.2996"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-18.0161%"
percent_change_from_50_day_moving_average="-7.4661%"
percent_change_from_52_week_high="-74.0625%"
percent_change_from_52_week_low="+3.0142%"
previous_close="0.2899"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7256"
price_per_sales="1.3685"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.2600"
stock_exchange="NCM"
symbol="PPHM"
volume="1295820"
weeks_range_52="0.2820 - 1.1200"
